UP!

RPXC $10.48

RPXC target price
10.48
0
0
RPX Corporation
Type
Public
Traded as NASDAQ: RPXC
Industry Business & Personal Services
Founded 2008; 9 years ago (2008)
Founders John A. Amster, Geoffrey T. Barker, Eran Zur
Headquarters San Francisco, California
Key people
Marty Roberts, CEO and President
Products RPX Insight, RPX Insurance
Revenue $333.1 million
Website www.rpxcorp.com

RPX Corporation (Rational Patent EXchange)(NASDAQ: RPXC) is an American worldwide provider of patent risk management services, offering defensive buying, acquisition syndication, patent intelligence and advisory services. Since the company was founded in March, 2008, RPX claims to have introduced efficiency to the patent market by providing a rational alternative to litigation. RPX is based in San Francisco. By acquiring patents that pose potential problems and providing information on litigation, RPX seeks to reduce patent assertions directed at its clients.

RPX provides a Defensive Patent Aggregation service to mitigate clients’ risk of litigation from non-practicing entities (NPEs) – also called patent trolls – which acquire patents for the sole purpose of licensing and asserting their patent rights.

RPX identifies and purchases patent assets they identify as of high value, relevance and risk that could be used offensively against members of the company's client network. Depending on the situation, RPX may acquire assets from a third party or directly from an NPE. When necessary and possible, RPX will buy patent rights out of an active litigation.

RPX promises to never assert or litigate the patents in its portfolio.

RPX's service is designed to mitigate members’ litigation risk and costs from NPEs by purchasing patents and patent rights before patents are asserted, or to resolve an ongoing litigation.

RPX clients receive a license to all of the patents and associated rights aggregated in the RPX portfolio. Over time, RPX clients receive perpetual license to the patents held when they became members or purchased after they joined, as well as any patents sold during their membership.

The service is structured on an annual membership. Annual membership fees may increase each year to account for the growing value of the RPX portfolio, but early-joining members lock in a lower rate. Companies that join the RPX client network later receive the same benefits, but must pay the then-current rates.

RPX provides data services as part of its membership. The RPX client portal provides data related to patents and patents available for sale, historical and current patent litigation and NPEs. however the product is not publicly available (exclusive to RPX members) and it has yet to be seen how the RPX portal compares to other services. In May 2014, to increase transparency, the company released RPX Search - a search engine that provides free public access to most of its data - independent of RPX membership.

RPX was founded in 2008 by John Amster, Geoffrey Barker and Eran Zur. The company was initially financed by Kleiner Perkins Caufield & Byers, Charles River Ventures, and Index Ventures.

In its first year, RPX generated $0.8 million revenue in that year. Revenue grew to $32.8 million in 2009, reaching profitability. In the first nine months of 2010 RPX earned $10 million in profit on $65.2 million in revenue.. RPX's revenue for the year 2016 was $333.1 million.

RPX filed an S1 on January 21, 2011 and RPX began publicly trading on the NASDAQ exchange as "RPXC" in May 2011.

RPX arranged a consortium to purchase 4000 Nortel patents from the Rockstar Consortium in December 2014.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-07 Lower Price Target Barclays PLC Underweight $10.00 to $9.00
2016-02-11 Lower Price Target Barclays Underweight $12.00 to $10.00
2016-02-11 Lower Price Target Barclays PLC Underweight $12.00 to $10.00
2016-02-10 Lower Price Target Cowen and Company Outperform $17.00 to $14.00
2016-01-05 Lower Price Target Barclays Underweight $15.00 to $12.00
2015-12-16 Downgrade Robert W. Baird Outperform to Neutral $18.00 to $14.00
2015-11-03 Lower Price Target Cowen and Company Outperform $20.00 to $16.00
2015-11-02 Lower Price Target Barclays Equal Weight $16.00 to $15.00
2015-10-28 Reiterated Rating Cowen and Company Outperform $18.00 to $17.00
2015-08-20 Downgrade Barclays Equal Weight to Underweight $15.00
2015-07-29 Reiterated Rating Cowen and Company Outperform $16.00 to $18.00
2015-05-04 Reiterated Rating JPMorgan Chase & Co. Neutral $14.00 to $15.00
2015-02-11 Reiterated Rating JPMorgan Chase & Co. Hold $16.00 to $14.00
2015-02-11 Lower Price Target Barclays Equal Weight $16.00 to $15.00
2015-02-11 Lower Price Target Cowen and Company Outperform $20.00 to $16.00
2014-08-04 Downgrade Barclays Overweight to Equal Weight $20.00 to $17.00
2014-07-21 Reiterated Rating JPMorgan Chase & Co. Neutral $18.50 to $19.00
2014-03-17 Initiated Cowen Outperform $20
2014-03-17 Initiated Coverage Cowen and Company Outperform $20.00
2013-10-30 Boost Price Target Barclays Overweight $18.00 to $20.00
2012-07-05 Initiated GARP Research Buy
2016-07-07 Lower Price Target Barclays PLC Underweight $10.00 to $9.00
2016-02-11 Lower Price Target Barclays Underweight $12.00 to $10.00
2016-02-11 Lower Price Target Barclays PLC Underweight $12.00 to $10.00
2016-02-10 Lower Price Target Cowen and Company Outperform $17.00 to $14.00
2016-01-05 Lower Price Target Barclays Underweight $15.00 to $12.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
Amster John A Chief Executive Officer 1.91%  (1026710) RPXC /
ROBERTSON SANFORD 0.46%  (244610) CRM / DLB / PTIE / RPXC /
ROBERTS MARTIN E SVP, Gen. Counsel & Secretary 0.32%  (171238) RPXC /
Yen Mallun Executive Vice President 0.28%  (151755) RPXC /
Fingerhood Steven L 0.17%  (88714) HPOL / RPXC /
HEATH ROBERT H Chief Financial Officer, SVP 0.12%  (63626) RPXC /
RYDER THOMAS O 0.10%  (53292) AMZN / HOT / IILG / QUAD / RPXC /
Dangeard Frank E 0.08%  (42195) RPXC / SYMC /
YESIL MAGDALENA 0.07%  (35257) RPXC /
MANKOO PAUL CEO, Inventus 0.07%  (35073) RPXC /
AFRICK ANDREW 0.06%  (34084) ALQA / RPXC / STRI / SXC /
SEGAL NED D. Chief Financial Officer, SVP 0.06%  (32410) RPXC /
Palter Gilbert Samuel 0.06%  (30734) AT / RPXC /
Barker Geoffrey T Executive Director 0.05%  (29399) RPXC /
ANDERSON DAVID JAMES Chief Financial Officer 0.05%  (28107) RPXC /
BONNIE SHELBY W 0.05%  (24757) RPXC /
Campion Trevor CEO, Inventus 0.03%  (17449) RPXC /
SWANK STEVEN S Senior Vice President 0.02%  (11811) RPXC /
KOMISAR RANDY 0.02%  (9498) RPXC /